DLL4+ neutrophils induce alveolar macrophages to cause ADAM-17–mediated endothelial barrier disruption and the increase of ICAM1hiCXCR1lo neutrophils in sepsis
Journal of Leukocyte Biology · 2026
DOI: 10.1093/jleuko/qiag097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2026. Verfasst von Hui Jin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Immunology and Inflammation, The Feinstein Institutes for Medical Research, 350 Community Dr., Manhasset, NY 11030, United States. Hauptthemen laut MEDLINE: ADAM17 Protein, Sepsis, Intercellular Adhesion Molecule-1, Macrophages, Alveolar. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, National Institutes of Health.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis remains a leading cause of death. Reverse migrated neutrophils, characterized as ICAM1hiCXCR1lo, have been recognized as a key driver of systemic inflammation and organ injury in sepsis. We discovered a distinct delta-like ligand 4–positive (DLL4+) subset of neutrophils that accumulate in the lungs, contributing to lung injury; however, the underlying mechanism is less understood. In sepsis, ICAM1hiCXCR1lo neutrophils, being hyperactive, are detrimental. Here, we investigated how DLL4+ neutrophils activate alveolar macrophages (AMs) to cause endothelial cell barrier disruption and promote neutrophil reverse migration. AMs were treated with DLL4+ neutrophils or recombinant mouse DLL4, and a disintegrin and metalloprotease (ADAM17) generated by AMs was assessed at both mRNA and protein levels. Conditioned medium was subsequently applied to pulmonary vascular endothelial cells (pVECs); junctional adhesion molecule-C (JAM-C) protein was detected by Western blot assays; and ICAM1hiCXCR1lo neutrophils were detected by flow cytometry. We demonstrate that during sepsis induced by cecal ligation and puncture (CLP), DLL4+ neutrophils interact with AMs via the Notch1 pathway, leading to increase of ADAM17 expression. ADAM17 decreased JAM-C on pVECs, causing endothelial barrier disruption and ICAM1hiCXCR1lo neutrophil generation. A small-molecule inhibitor of ADAM17 effectively preserved pulmonary endothelial barrier integrity and reduced ICAM1hiCXCR1lo neutrophil accumulation. Importantly, we have developed a novel DLL4-Notch1 inhibitory peptide (NDI) that effectively suppresses ADAM17 expression, restores JAM-C, and reduces ICAM1hiCXCR1lo neutrophil accumulation in sepsis. These findings identify DLL4+ neutrophils as critical inflammatory mediators that exacerbate systemic inflammation and worsen sepsis, and highlight the DLL4-Notch1-ADAM17 axis as a promising therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Immunology and Inflammation, The Feinstein Institutes for Medical Research, 350 Community Dr., Manhasset, NY 11030, United States.
- Departments of Surgery and Molecular Medicine, Zucker School of Medicine, 350 Community Dr., Manhasset, NY 11030, United States.
ORCID-Profile: Monowar Aziz, Ping Wang
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Jin, H., Holland, S., Jha, A., Aziz, M., & Wang, P. (2026). DLL4+ neutrophils induce alveolar macrophages to cause ADAM-17–mediated endothelial barrier disruption and the increase of ICAM1hiCXCR1lo neutrophils in sepsis. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiag097
Vancouver
Jin H, Holland S, Jha A, Aziz M, Wang P. DLL4+ neutrophils induce alveolar macrophages to cause ADAM-17–mediated endothelial barrier disruption and the increase of ICAM1hiCXCR1lo neutrophils in sepsis. Journal of Leukocyte Biology. 2026. doi:10.1093/jleuko/qiag097
BibTeX
@article{Jin2026,
author = {Jin, Hui and Holland, Saoirse and Jha, Alok and Aziz, Monowar and Wang, Ping},
title = {DLL4+ neutrophils induce alveolar macrophages to cause ADAM-17–mediated endothelial barrier disruption and the increase of ICAM1hiCXCR1lo neutrophils in sepsis},
journal = {Journal of Leukocyte Biology},
year = {2026},
doi = {10.1093/jleuko/qiag097}
}
EUVIMED